Human lung cancer: role of TLR7 and TLR8 in cell survival and chemoresistance

被引：4
|
作者：
Cherfils-Vicini, Julien [1 ,2 ,3 ]
Damotte, Diane [1 ,2 ,3 ,4 ]
Fridman, Wolf-Herman [1 ,2 ,3 ,5 ]
Sautes-Fridman, Catherine [1 ,2 ,3 ]
Cremer, Isabelle [1 ,2 ,3 ]
机构：
[1] Ctr Rech Cordeliers, INSERM, U872, F-75006 Paris, France
[2] Univ Paris 06, UMRS 872, F-75006 Paris, France
[3] Univ Paris 05, UMRS 872, F-75006 Paris, France
[4] Hop Hotel Dieu, AP HP, Serv Anatomopathol, F-75005 Paris, France
[5] Hop Europeen Georges Pompidou, Serv Immunol Biol, AP HP, F-75015 Paris, France
来源：
M S-MEDECINE SCIENCES | 2010年 / 26卷 / 04期
关键词：
NF-KAPPA-B; INFLAMMATION;
D O I：
10.1051/medsci/2010264435
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：435 / 437
页数：3
相关论文
共 50 条
  • [1] Triggering of TLR7 and TLR8 expressed by human lung cancer cells induces cell survival and chemoresistance
    Cherfils-Vicini, Julien
    Platonova, Sophia
    Gillard, Melanie
    Laurans, Ludivine
    Validire, Pierre
    Caliandro, Rafaele
    Magdeleinat, Pierre
    Mami-Chouaib, Fathia
    Dieu-Nosjean, Marie-Caroline
    Fridman, Wolf-Herman
    Damotte, Diane
    Sautes-Fridman, Catherine
    Cremer, Isabelle
    JOURNAL OF CLINICAL INVESTIGATION, 2010, 120 (04): : 1285 - 1297
  • [2] The role of TLR7 and TLR8 expression in tumor cell proliferation and chemoresistance in pancreatic cancer
    Gasser, Martin
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2015, 36 : S107 - S107
  • [3] TLR7 and TLR8 expression increases tumor cell proliferation and promotes chemoresistance in human pancreatic cancer
    Grimmig, Tanja
    Matthes, Niels
    Hoeland, Katharina
    Tripathi, Sudipta
    Chandraker, Anil
    Grimm, Martin
    Moench, Romana
    Moll, Eva-Maria
    Friess, Helmut
    Tsaur, Igor
    Blaheta, Roman A.
    Germer, Cristoph T.
    Waaga-Gasser, Ana Maria
    Gasser, Martin
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2015, 47 (03) : 857 - 866
  • [4] TLR7 and TLR8 as targets in cancer therapy
    M P Schön
    M Schön
    Oncogene, 2008, 27 : 190 - 199
  • [5] TLR7 and TLR8 as targets in cancer therapy
    Schoen, M. P.
    Schoen, M.
    ONCOGENE, 2008, 27 (02) : 190 - 199
  • [6] The use of TLR7 and TLR8 ligands for the enhancement of cancer immunotherapy
    Smits, Evelien L. J. M.
    Ponsaerts, Peter
    Berneman, Zwi N.
    Van Tendeloo, Viggo F. I.
    ONCOLOGIST, 2008, 13 (08): : 859 - 875
  • [7] Nucleosides are endogenous ligands for TLR7 and TLR8
    Shibata, Takuma
    Ohto, Umeharu
    Tanji, Hiromi
    Shimizu, Toshiyuki
    Miyake, Kensuke
    CYTOKINE, 2017, 100 : 77 - 77
  • [8] Characterization of TLR7 and TLR8 in Rheumatoid Arthritis
    Chamberlain, Nathan D.
    Volin, Michael
    Pope, Richard M.
    Mandelin, Arthur M., II
    Shahrara, Shiva
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S136 - S136
  • [9] Porcine TLR8 and TLR7 are both activated by a selective TLR7 ligand, imiquimod
    Zhu, Jianzhong
    Lai, Ken
    Brownile, Robert
    Babiuk, Lorne A.
    Mutwiri, George K.
    MOLECULAR IMMUNOLOGY, 2008, 45 (11) : 3238 - 3243
  • [10] TLR7/8 agonists activate a mild immune response in rabbits through TLR8 but not TLR7
    Lai, Chao-Yang
    Liu, Yi-Ling
    Yu, Guann-Yi
    Maa, Ming-Chei
    Leu, Tzeng-Horng
    Xu, Congfeng
    Luo, Yunping
    Xian, Rong
    Chuang, Tsung-Hsien
    VACCINE, 2014, 32 (43) : 5593 - 5599
12345